Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-2.90
↑ 71% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-10.05
Historical baseline
PeriodValueYoY Change
2025-2.90+50.8%
2024-5.89-18.4%
2023-4.98-53.2%
2022-3.25+70.5%
2021-11.03+56.7%
2020-25.47-22.7%
2019-20.76-147.0%
2018-8.40-28.4%
2017-6.55+41.7%
2016-11.23-